EXHIBIT 4.8

SECOND OMNIBUS AMENDMENT

This Second Omnibus Amendment, dated September 24, 2007, by and between ON THE
GO HEALTHCARE, INC., a Delaware Corporation (the "Company"), and Laurus Master
Fund, Ltd., a Cayman Islands company ("Laurus", and together with the
undersigned assignees of Laurus, collectively, the "Purchaser"), amends (i)
that certain Secured Convertible Minimum Borrowing Note, dated July 14, 2005
by the Company in favor of Purchaser in the aggregate principal amount of
$2,500,000 (as amended, restated, modified or supplemented from time to time,
the "Minimum Borrowing Note") issued pursuant to the terms of the Security
and Purchase Agreement, dated July 14, 2005 between the Company and the
Purchaser (as amended, restated, modified or supplemented from time to time,
the "Purchase Agreement") issued pursuant to the terms of the Purchase
Agreement.  The Purchase Agreement, together with the Minimum Borrowing
Note and the other Ancillary Documents referred to in the Purchase Agreement,
are herein referred to as the "Loan Documents."  Capitalized terms used but
not defined herein shall have the meanings given them in the Purchase
Agreement.

PREAMBLE

        WHEREAS, pursuant to the terms of the Purchase Agreement, the Company
        issued and sold the Minimum Borrowing Note to Purchaser; and

        WHEREAS, the Purchaser and the Company desire to amend the transactions
        contemplated by the Purchase Agreement and the Minimum Borrowing Note.

        NOW, THEREFORE, in consideration of the covenants, agreements and
        conditions hereinafter set forth, and other good and valuable
        consideration, the receipt and sufficiency of which are hereby
        acknowledged, the parties hereto agree as follows:

1.  Amendment to Minimum Borrowing Note.  Section 3.1 of the Minimum Borrowing
    Note is hereby amended by deleting the last two sentences appearing therein
    in its entirety and inserting the following new sentence in lieu thereof:

        "For purposes hereof, subject to Section 3.6 hereof, the initial "Fixed
        Conversion Price" means: (a)  with respect to the first $150,000 of
        principal converted hereunder after September 24, 2007, $0.005; and
        (b) with respect to the remainder of principal and interest converted
        hereunder after the conversion described in Section 3.1(a) hereof,
        $1.02.  The shares of Common Stock to be issued upon such conversion
        are herein referred to as the "Conversion Shares")."


2.  The Company hereby agrees to cover any and all expense related to the
    issuance of a legal opinion issued for the benefit of the Company's transfer
    agent, if required, so that Purchaser may sell the common stock issued by
    the Company upon conversion of the Notes pursuant to Rule 144(k).
    Purchaser acknowledges that the Company will not amend the Registration
    Statement and the Purchaser may not sell the common stock issued by the
    Company upon conversion of the Minimum Borrowing Note pursuant to the
    Registration Statement. However, this paragraph will not apply to the
    common stock issuable upon exercise of the warrants described in the
    Registration Statement.

3.  The Purchaser acknowledges that the reduction in conversion price described
    in paragraphs 1 above will require the Company to issue more shares of
    common stock.

<PAGE>

4.  Additionally, the Purchaser and the Company agree that such reduction in
    price does not trigger any clause in the Minimum Borrowing Note or any
    other agreement between the Purchaser and the Company to reduce the
    conversion price or exercise price of other securities.

5.  The Purchaser agrees that such reduction in price and the subsequent
    issuance of shares will not trigger a default under any agreement between
    the Purchaser and the Company.

6.  The amendments set forth above shall be effective as of the date first
    above written (the "Amendment Effective Date") on the date when each of
    the Company and the Purchaser shall have executed and the Company shall
    have delivered to Purchaser its respective counterpart to this Amendment.

7.  Except as specifically set forth in this Amendment, there are no other
    amendments, modifications or waivers to the Loan Documents, and all of
    the other forms, terms and provisions of the Loan Documents remain in
    full force and effect.

8.  The Company hereby represents and warrants to the Purchaser that (i) no
    Event of Default (as defined in the Purchase Agreement) exists on the
    date hereof, (ii) on the date hereof, all representations, warranties
    and covenants made by the Company in connection with the Loan Documents
    are true, correct and complete and (iii) on the date hereof, all of the
    Company's and its Subsidiaries' covenant requirements have been met.

9.  From and after the Amendment Effective Date, all references in the Loan
    Documents shall be deemed to be references to the Loan Documents, as the
    case may be, as modified hereby.

10. This Amendment shall be binding upon the parties hereto and their
    respective successors and permitted assigns and shall inure to the benefit
    of and be enforceable by each of the parties hereto and their respective
    successors and permitted assigns.  THIS AMENDMENT SHALL BE CONSTRUED AND
    ENFORCED IN ACCORDANCE WITH AND GOVERNED BY THE LAW OF THE STATE OF NEW
    YORK.  This Amendment may be executed in any number of counterparts,
    each of which shall be an original, but all of which shall constitute
    one instrument.



IN WITNESS WHEREOF, each of the parties hereto has executed this Amendment or
has caused this Amendment to be executed on its behalf by a representative
duly authorized, all as of the date first above set forth.


COMPANY:                PURCHASER:

ON THE GO HEALTHCARE, INC.              LAURUS MASTER FUND, LTD.



By:     /s/ Stuart Turk                 By:     /s/ David Grin
-------------------------------         --------------------------------
Name:   Stuart Turk                     Name:   David Grin
Title:  Chief Executive Officer         Title:  Director



<PAGE>